|
ADD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.438400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.010050E-01 |
| Normal-vs-Stage2 |
5.903800E-01 |
| Normal-vs-Stage3 |
5.721500E-02 |
| Normal-vs-Stage4 |
1.625170E-01 |
| Stage1-vs-Stage2 |
9.459700E-02 |
| Stage1-vs-Stage3 |
5.013800E-04 |
| Stage1-vs-Stage4 |
7.081300E-03 |
| Stage2-vs-Stage3 |
4.963000E-01 |
| Stage2-vs-Stage4 |
6.730200E-01 |
| Stage3-vs-Stage4 |
7.352400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.484600E-01 |
| Normal-vs-AfricanAmerican |
4.589200E-01 |
| Normal-vs-Asian |
4.769200E-01 |
| Caucasian-vs-AfricanAmerican |
2.918200E-01 |
| Caucasian-vs-Asian |
5.613800E-01 |
| AfricanAmerican-vs-Asian |
8.895800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.518400E-01 |
| Normal-vs-Female |
2.743800E-01 |
| Male-vs-Female |
4.351900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.914200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.536800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.667200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.010200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.775000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.638800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.772400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.461250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.329400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.161200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.58559999966046E-07 |
| Normal-vs-Grade 2 |
1.089370E-01 |
| Normal-vs-Grade 3 |
3.215600E-01 |
| Normal-vs-Grade 4 |
2.797200E-03 |
| Grade 1-vs-Grade 2 |
9.93089999999919E-05 |
| Grade 1-vs-Grade 3 |
1.9224999999734E-06 |
| Grade 1-vs-Grade 4 |
3.88149999919207E-08 |
| Grade 2-vs-Grade 3 |
5.544200E-03 |
| Grade 2-vs-Grade 4 |
3.97119999999695E-05 |
| Grade 3-vs-Grade 4 |
2.789800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.620260E-03 |
| Normal-vs-ccB subtype |
1.358280E-03 |
| ccA subtype-vs-ccB subtype |
1.53520529622142E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.000000E-01 |
| Normal-vs-N1 |
7.240600E-01 |
| N0-vs-N1 |
8.421600E-01 |
|
|
